Literature DB >> 17921589

Biologically-equivalent dose and long-term survival time in radiation treatments.

Marco Zaider1, Leonid Hanin.   

Abstract

Within the linear-quadratic model the biologically-effective dose (BED)-taken to represent treatments with an equal tumor control probability (TCP)-is commonly (and plausibly) calculated according to BED(D) = -log[S(D)]/alpha. We ask whether in the presence of cellular proliferation this claim is justified and examine, as a related question, the extent to which BED approximates an isoeffective dose (IED) defined, more sensibly, in terms of an equal long-term survival probability, rather than TCP. We derive, under the assumption that cellular birth and death rates are time homogeneous, exact equations for the isoeffective dose, IED. As well, we give a rigorous definition of effective long-term survival time, T(eff). By using several sets of radiobiological parameters, we illustrate potential differences between BED and IED on the one hand and, on the other, between T(eff) calculated as suggested here or by an earlier recipe. In summary: (a) the equations currently in use for calculating the effective treatment time may underestimate the isoeffective dose and should be avoided. The same is the case for the tumor control probability (TCP), only more so; (b) for permanent implants BED may be a poor substitute for IED; (c) for a fractionated treatment schedule, interpreting the observed probability of cure in terms of a TCP formalism that refers to the end of the treatment (rather than T(eff)) may result in a miscalculation (underestimation) of the initial number of clonogens.

Entities:  

Mesh:

Year:  2007        PMID: 17921589     DOI: 10.1088/0031-9155/52/20/017

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

Review 1.  Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.

Authors:  George Sgouros; Robert F Hobbs; Francis B Atkins; Douglas Van Nostrand; Paul W Ladenson; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

2.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.

Authors:  Zhe Jay Chen; Kenneth Roberts; Roy Decker; Pradip Pathare; Sara Rockwell; Ravinder Nath
Journal:  Phys Med Biol       Date:  2011-07-19       Impact factor: 3.609

4.  A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.

Authors:  Robert F Hobbs; Todd McNutt; Sébastien Baechler; Bin He; Caroline E Esaias; Eric C Frey; David M Loeb; Richard L Wahl; Ori Shokek; George Sgouros
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

Review 5.  Three-dimensional imaging-based radiobiological dosimetry.

Authors:  George Sgouros; Eric Frey; Richard Wahl; Bin He; Andrew Prideaux; Robert Hobbs
Journal:  Semin Nucl Med       Date:  2008-09       Impact factor: 4.446

6.  Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.

Authors:  Piernicola Pedicini; Rocchina Caivano; Barbara Alicia Jereczek-Fossa; Lidia Strigari; Barbara Vischioni; Daniela Alterio; Marta Cremonesi; Francesca Botta; Antonio Nappi; Giuseppina Improta; Giovanni Storto; Marcello Benassi; Roberto Orecchia
Journal:  Theor Biol Med Model       Date:  2012-06-19       Impact factor: 2.432

7.  Radiobiologically based treatment plan evaluation for prostate seed implants.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Carlos Esquivel; Dimos Baltas; Sotirios Stathakis; Gregory Swanson; Nikos Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-07-06

8.  Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Sotirios Stathakis; Mark Smith; Gregory Swanson; Niko Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.